You are here

epidermolysis bullosa

Chiesi Rare Skin Disease Drug Acquired in Billion Dollar Deal Wins FDA Approval

MedCity News

Tue, 12/19/23 - 11:13 pm

epidermolysis bullosa

Amryt Pharma Shares Tumble After FDA Rejects Oleogel-S10 Application

Marketwatch

Mon, 02/28/22 - 11:29 am

epidermolysis bullosa

Krystal shines in epidermolysis bullosa

EP Vantage

Tue, 11/30/21 - 10:22 am

Krystal Biotech

clinical trials

epidermolysis bullosa

Epidermolysis bullosa gene therapies wait in the wings

EP Vantage

Thu, 04/29/21 - 10:50 am

epidermolysis bullosa

Maker of world's most expensive prescription drug flashes PhIII data for a potential fourth product

Endpoints

Wed, 09/9/20 - 10:31 am

clinical trials

epidermolysis bullosa

Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3

Xconomy

Wed, 09/13/17 - 09:39 am

clinical trials

epidermolysis bullosa

Drug developer gets Scioderm FDA cash to work on orphan disease drug

Bizjournals.com

Tue, 09/22/15 - 09:51 am

epidermolysis bullosa

RegeneRx says Phase 2 trial met primary outcome measure

Yahoo/Fly on the Wall

Mon, 06/24/13 - 10:42 am

epidermolysis bullosa